IL62517A - Pharmaceutical compositions comprising cisplatin - Google Patents

Pharmaceutical compositions comprising cisplatin

Info

Publication number
IL62517A
IL62517A IL62517A IL6251781A IL62517A IL 62517 A IL62517 A IL 62517A IL 62517 A IL62517 A IL 62517A IL 6251781 A IL6251781 A IL 6251781A IL 62517 A IL62517 A IL 62517A
Authority
IL
Israel
Prior art keywords
cisplatin
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL62517A
Other languages
English (en)
Other versions
IL62517A0 (en
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of IL62517A0 publication Critical patent/IL62517A0/xx
Publication of IL62517A publication Critical patent/IL62517A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL62517A 1980-03-31 1981-03-30 Pharmaceutical compositions comprising cisplatin IL62517A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13537380A 1980-03-31 1980-03-31

Publications (2)

Publication Number Publication Date
IL62517A0 IL62517A0 (en) 1981-05-20
IL62517A true IL62517A (en) 1984-01-31

Family

ID=22467813

Family Applications (1)

Application Number Title Priority Date Filing Date
IL62517A IL62517A (en) 1980-03-31 1981-03-30 Pharmaceutical compositions comprising cisplatin

Country Status (30)

Country Link
JP (1) JPS56152415A (de)
KR (1) KR860000841B1 (de)
AR (1) AR225500A1 (de)
AT (1) AT370996B (de)
AU (1) AU541056B2 (de)
BE (1) BE888209A (de)
CA (1) CA1162479A (de)
CH (1) CH647481A5 (de)
CS (1) CS246051B2 (de)
DD (1) DD157762A5 (de)
DE (1) DE3112272A1 (de)
DK (1) DK158564C (de)
ES (1) ES500869A0 (de)
FI (1) FI70670C (de)
FR (1) FR2480605A1 (de)
GB (1) GB2074028B (de)
GR (1) GR72769B (de)
HU (1) HU183379B (de)
IE (1) IE51070B1 (de)
IL (1) IL62517A (de)
IT (1) IT1170838B (de)
LU (1) LU83270A1 (de)
NL (1) NL8101531A (de)
NO (1) NO156675C (de)
NZ (1) NZ196519A (de)
PH (1) PH17152A (de)
PT (1) PT72774B (de)
SE (1) SE455045B (de)
SU (1) SU1056893A3 (de)
ZA (1) ZA812084B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1153974B (it) * 1982-09-23 1987-01-21 Erba Farmitalia Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
FI895340A0 (fi) * 1988-11-14 1989-11-09 Bristol Myers Squibb Co Hypertonisk cisplatin-loesning.
DE69725747T2 (de) * 1996-08-23 2004-07-29 Sequus Pharmaceuticals, Inc., Menlo Park Liposome enthaltend cisplatin
AUPQ641100A0 (en) 2000-03-23 2000-04-15 Australia Nuclear Science & Technology Organisation Methods of synthesis and use of radiolabelled platinum chemotherapeutic ag ents
JP4445304B2 (ja) 2004-03-26 2010-04-07 オンキヨー株式会社 スイッチングアンプ
US8852566B2 (en) * 2009-03-26 2014-10-07 Warsaw Orthopedic, Inc. Compositions and methods for preferential distribution of active agents to injury sites
KR20200136997A (ko) 2018-03-29 2020-12-08 프로젝트 파마슈틱스 게엠베하 액체 약학적 제형

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4177263A (en) * 1972-02-28 1979-12-04 Research Corporation Anti-animal tumor method
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform

Also Published As

Publication number Publication date
GB2074028A (en) 1981-10-28
BE888209A (fr) 1981-09-30
FR2480605B1 (de) 1984-05-11
DE3112272C2 (de) 1990-09-27
AR225500A1 (es) 1982-03-31
DK144281A (da) 1981-10-01
DD157762A5 (de) 1982-12-08
JPS6360008B2 (de) 1988-11-22
DK158564C (da) 1990-11-05
IE51070B1 (en) 1986-09-17
NZ196519A (en) 1983-06-17
IE810715L (en) 1981-09-30
SU1056893A3 (ru) 1983-11-23
CA1162479A (en) 1984-02-21
DK158564B (da) 1990-06-11
ES8206545A1 (es) 1982-08-16
IL62517A0 (en) 1981-05-20
AU6816681A (en) 1981-10-08
AT370996B (de) 1983-05-25
CH647481A5 (fr) 1985-01-31
HU183379B (en) 1984-04-28
PT72774B (en) 1982-11-16
DE3112272A1 (de) 1982-04-29
PT72774A (en) 1981-04-01
GB2074028B (en) 1983-09-21
SE455045B (sv) 1988-06-20
ZA812084B (en) 1982-04-28
NO156675C (no) 1987-11-04
JPS56152415A (en) 1981-11-26
FI810934L (fi) 1981-10-01
KR830004849A (ko) 1983-07-20
FR2480605A1 (fr) 1981-10-23
PH17152A (en) 1984-06-13
ATA150481A (de) 1982-10-15
IT8148090A0 (it) 1981-03-24
FI70670C (fi) 1986-10-06
CS246051B2 (en) 1986-10-16
FI70670B (fi) 1986-06-26
IT1170838B (it) 1987-06-03
NL8101531A (nl) 1981-10-16
AU541056B2 (en) 1984-12-13
LU83270A1 (fr) 1981-10-29
KR860000841B1 (ko) 1986-07-09
NO156675B (no) 1987-07-27
GR72769B (de) 1983-12-02
SE8101990L (sv) 1981-11-13
ES500869A0 (es) 1982-08-16
NO811081L (no) 1981-10-01

Similar Documents

Publication Publication Date Title
GB8326565D0 (en) Pharmaceutical compositions
ZA813465B (en) Pharmaceutical composition
HK16090A (en) Pharmaceutical compositions
ZA833781B (en) Pharmaceutical compositions
ZA81136B (en) Pharmaceutical compositions
GB2118176B (en) Pharmaceutical compositions
GB2117766B (en) Pharmaceutical compositions
GB8324133D0 (en) Pharmaceutical compositions
GB2072504B (en) Pharmaceutical compositions
GB8429749D0 (en) Pharmaceutical compositions
IL62517A0 (en) Pharmaceutical compositions comprising cisplatin
ZA815700B (en) Pharmaceutical compositions
GB8313814D0 (en) Pharmaceutical compositions
DE3377696D1 (en) Pharmaceutical compositions
US4594359B1 (en) Pharmaceutical compositions
GB2114001B (en) Nasel pharmaceutical compositions
IL62432A0 (en) Pharmaceutical compositions based on sulphonamide-potentiator combinations
PT73952B (en) Pharmaceutical compositions
DE3176849D1 (en) Pharmaceutical composition comprising 4-carbamoyl-imidazolium-5-olate
GB8305028D0 (en) Pharmaceutical compositions
GB8330810D0 (en) Pharmaceutical compositions
GB8314736D0 (en) Pharmaceutical compositions
ZA815175B (en) Pharmaceutical composition
GB8331068D0 (en) Pharmaceutical compositions
GB8329391D0 (en) Pharmaceutical compositions